» Articles » PMID: 36969211

Active Ingredients of Traditional Chinese Medicine for Enhancing the Effect of Tumor Immunotherapy

Overview
Journal Front Immunol
Date 2023 Mar 27
PMID 36969211
Authors
Affiliations
Soon will be listed here.
Abstract

Immunotherapy is a type of treatment that uses our own immune system to fight cancer. Studies have shown that traditional Chinese medicine (TCM) has antitumor activity and can enhance host immunity. This article briefly describes the immunomodulatory and escape mechanisms in tumors, as well as highlights and summarizes the antitumor immunomodulatory activities of some representative active ingredients of TCM. Finally, this article puts forward some opinions on the future research and clinical application of TCM, aiming to promote the clinical applications of TCM in tumor immunotherapy and to provide new ideas for the research of tumor immunotherapy using TCM.

Citing Articles

Recent advances in self-targeting natural product-based nanomedicines.

Liu H, Jin X, Liu S, Liu X, Pei X, Sun K J Nanobiotechnology. 2025; 23(1):31.

PMID: 39833846 PMC: 11749302. DOI: 10.1186/s12951-025-03092-9.


The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review.

Li Y, Li C, Fan J, Liu Y, Xu Y, Pang G Cancer Manag Res. 2025; 17():23-34.

PMID: 39816489 PMC: 11734505. DOI: 10.2147/CMAR.S503071.


Modulating Endoplasmic Reticulum Stress in Gastrointestinal Cancers: Insights from Traditional Chinese Medicine.

Li Q, Zhao X, Yang H, Zhu X, Sui X, Feng J Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770441 PMC: 11676909. DOI: 10.3390/ph17121599.


Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.

Guo K, Wang Z, Su X Chin J Integr Med. 2024; .

PMID: 39331211 DOI: 10.1007/s11655-024-4115-8.


Screening of herbal extracts binding with vascular endothelial growth factor by applying HerboChip platform.

Liu Y, Liang J, Guo G, Qiu Y, Yu L, Tsim K Chin Med. 2024; 19(1):122.

PMID: 39252102 PMC: 11382504. DOI: 10.1186/s13020-024-00987-x.


References
1.
Rawangkan A, Wongsirisin P, Namiki K, Iida K, Kobayashi Y, Shimizu Y . Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth. Molecules. 2018; 23(8). PMC: 6222340. DOI: 10.3390/molecules23082071. View

2.
Chhabra G, Singh C, Amiri D, Akula N, Ahmad N . Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment. Molecules. 2021; 26(5). PMC: 7959117. DOI: 10.3390/molecules26051343. View

3.
Shah D, Challagundla N, Dave V, Patidar A, Saha B, Nivsarkar M . Berberine mediates tumor cell death by skewing tumor-associated immunosuppressive macrophages to inflammatory macrophages. Phytomedicine. 2022; 99:153904. DOI: 10.1016/j.phymed.2021.153904. View

4.
Qian H, Wang L, Li Y, Wang B, Li C, Fang L . The traditional uses, phytochemistry and pharmacology of Abrus precatorius L.: A comprehensive review. J Ethnopharmacol. 2022; 296:115463. DOI: 10.1016/j.jep.2022.115463. View

5.
Lee Y, Shin H, Kim J . In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation. J Innate Immun. 2020; 13(2):94-106. PMC: 8077674. DOI: 10.1159/000510315. View